These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7069666)

  • 1. Genetics of teratocarcinoma transplantation. III. Genetic control of resistance to F9 tumor formation in allogeneic hosts.
    Avner P; Simmler MC
    J Reprod Immunol; 1982 Feb; 4(1):31-7. PubMed ID: 7069666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of teratocarcinoma transplantation. II. Effect of a semidominant H-2-linked gene lying outside the immediate major histocompatibility complex on tumor formation by the embryonal carcinoma cell line F9 in H-2 congenic pairs.
    Avner P
    Transplantation; 1980 Sep; 30(3):185-90. PubMed ID: 14582174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3.
    Avner PR; Dove WF; Dubois P; Gaillard JA; Guénet JL; Jacob F; Jakob H; Shedlovsky A
    Immunogenetics; 1978 Dec; 7(1):103-15. PubMed ID: 21302063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The location of the C3 and GLO (glyoxalase 1) loci of the IXth linkage group in mice.
    Rubinstein P; Vienne K; Hoecker GF
    J Immunol; 1979 Jun; 122(6):2584-9. PubMed ID: 448134
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of natural killer activity in the resistance of allogeneic hosts to the embryonal carcinoma cell line F9.
    Simmler MC; Avner PR
    Am J Reprod Immunol (1980); 1982 Dec; 2(6):301-8. PubMed ID: 7158680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multigene control of Mlsc.
    Click RE; Adelmann A
    Immunogenetics; 1988; 28(6):412-6. PubMed ID: 3182015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mapping of the embryonal carcinoma transplantation resistance locus Gt(B6) to mouse Chromosome 8.
    Muller AJ; Heiden KB; Teresky AK; Levine AJ
    Immunogenetics; 1999 Oct; 49(11-12):949-56. PubMed ID: 10501837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection.
    Grundy JE; Mackenzie JS; Stanley NF
    Infect Immun; 1981 Apr; 32(1):277-86. PubMed ID: 6260682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2.
    Shedlovsky A; Clipson LJ; VandeBerg JL; Dove WF
    Immunogenetics; 1981; 13(5):413-9. PubMed ID: 7298086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2.
    Walker MC; Phillips-Quagliata JM
    J Immunol; 1979 Apr; 122(4):1535-43. PubMed ID: 448097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assignment of a gene that determines erythrocytic guanosine-5'-triphosphate concentration (Gtpc) to mouse chromosome 9.
    Jenuth JP; Fung E; Snyder FF
    Genome; 1994 Jun; 37(3):399-404. PubMed ID: 8034180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody gene linkage studies in (NZB X C58) recombinant-inbred lines.
    Riblet R; Claflin L; Gibson DM; Mathieson BJ; Weigert M
    J Immunol; 1980 Feb; 124(2):787-9. PubMed ID: 6766165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic linkage between Lym-1, Sas-1 and Mls loci.
    Dickler HB; Rosenstreich DL; Ahmed A; Sachs DH
    Immunogenetics; 1980; 10(1):93-6. PubMed ID: 6967858
    [No Abstract]   [Full Text] [Related]  

  • 17. Semisyngeneic hybrid resistance to murine teratocarcinoma cells.
    Bishop GA; Dove WF
    Immunogenetics; 1980; 10(4):383-93. PubMed ID: 22457930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia.
    Wagner H; Starzinski-Powitz A; Röllinghoff M; Golstein P; Jakob H
    J Exp Med; 1978 Jan; 147(1):251-64. PubMed ID: 415107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratocarcinoma transplantation antigens are encoded in the H-2 region.
    Johnson LL; Clipson LJ; Dove WF; Feilbach J; Maher LJ; Shedlovsky A
    Immunogenetics; 1983; 18(2):137-45. PubMed ID: 6350173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2 class I antigen expression on mouse teratocarcinoma cell lines.
    Démant P; Oudshoorn-Snoek M
    Immunogenetics; 1985; 22(6):543-52. PubMed ID: 4077148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.